AT350545B - Verfahren zur herstellung von neuen n- subistituierten carbonsaeureamiden - Google Patents

Verfahren zur herstellung von neuen n- subistituierten carbonsaeureamiden

Info

Publication number
AT350545B
AT350545B AT245377A AT245377A AT350545B AT 350545 B AT350545 B AT 350545B AT 245377 A AT245377 A AT 245377A AT 245377 A AT245377 A AT 245377A AT 350545 B AT350545 B AT 350545B
Authority
AT
Austria
Prior art keywords
subistituted
new
production
carbonic acid
acid amides
Prior art date
Application number
AT245377A
Other languages
German (de)
English (en)
Other versions
ATA245377A (de
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Priority to AT167678A priority Critical patent/AT354429B/de
Priority to AT167778A priority patent/AT356090B/de
Priority to AT167878A priority patent/AT355560B/de
Publication of ATA245377A publication Critical patent/ATA245377A/de
Application granted granted Critical
Publication of AT350545B publication Critical patent/AT350545B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12—Thioxanthenes
    • C07D335/20—Thioxanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/90—Xanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12—Thioxanthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT245377A 1976-07-02 1977-04-07 Verfahren zur herstellung von neuen n- subistituierten carbonsaeureamiden AT350545B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT167678A AT354429B (de) 1976-07-02 1978-03-08 Verfahren zur herstellung von neuen n- substituierten carbonsaeureamiden
AT167778A AT356090B (de) 1976-07-02 1978-03-08 Verfahren zur herstellung von neuen n- substituierten carbonsaeureamiden
AT167878A AT355560B (de) 1976-07-02 1978-03-08 Verfahren zur herstellung von neuen n-substi- tuierten carbonsaeureamiden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762629752 DE2629752A1 (de) 1976-07-02 1976-07-02 Neue carbonsaeurederivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ATA245377A ATA245377A (de) 1978-11-15
AT350545B true AT350545B (de) 1979-06-11

Family

ID=5982044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT245377A AT350545B (de) 1976-07-02 1977-04-07 Verfahren zur herstellung von neuen n- subistituierten carbonsaeureamiden

Country Status (11)

Country Link
US (1) US4136197A (US20020051482A1-20020502-M00057.png)
JP (1) JPS535148A (US20020051482A1-20020502-M00057.png)
AT (1) AT350545B (US20020051482A1-20020502-M00057.png)
BE (1) BE853258A (US20020051482A1-20020502-M00057.png)
CA (1) CA1104130A (US20020051482A1-20020502-M00057.png)
CH (3) CH627737A5 (US20020051482A1-20020502-M00057.png)
DE (1) DE2629752A1 (US20020051482A1-20020502-M00057.png)
DK (1) DK157677A (US20020051482A1-20020502-M00057.png)
FR (1) FR2356631A1 (US20020051482A1-20020502-M00057.png)
GB (1) GB1530062A (US20020051482A1-20020502-M00057.png)
NL (1) NL7703641A (US20020051482A1-20020502-M00057.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639935A1 (de) * 1976-09-04 1978-03-09 Hoechst Ag Benzoesaeuren und verfahren zu ihrer herstellung
GB8311678D0 (en) * 1983-04-28 1983-06-02 Ici Plc Phenol derivatives
IE58417B1 (en) * 1984-04-27 1993-09-22 Ici Plc Chemical derivatives
JPH0694464B2 (ja) * 1991-01-23 1994-11-24 協和醗酵工業株式会社 三環式化合物およびその中間体
US5266718A (en) * 1991-06-14 1993-11-30 Adir Et Compagnie Ethanolamine benzoate compounds
FR2677647B1 (fr) * 1991-06-14 1993-08-20 Adir Nouveaux derives de benzoate d'ethanolamine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2684101B1 (fr) * 1991-11-22 1993-12-31 Adir Cie Nouveaux derives de benzoate d'ethanolamine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5856340A (en) * 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US5856339A (en) * 1995-02-28 1999-01-05 Eli Lilly And Company Benzothiophene compounds, intermediates, compositions, and methods
WO1997046549A1 (en) * 1996-06-05 1997-12-11 Novartis Ag Anti-neurodegeneratively effective xanthene derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646009A (en) * 1967-03-15 1972-02-29 Boehringer & Soehne Gmbh Anti-diabetically active sulfonyl-semicarbazides
US3536753A (en) * 1969-05-27 1970-10-27 Geigy Chem Corp O-(substituted benzamido)phenylacetic acids
US3839433A (en) * 1971-06-28 1974-10-01 Ciba Geigy Corp Adamantylcarboxamidophenylalkanoic acids and esters thereof
JPS5640710B2 (US20020051482A1-20020502-M00057.png) * 1973-01-18 1981-09-22
GB1484413A (en) * 1974-04-18 1977-09-01 Kissei Pharmaceutical Aromatic amidocarboxylic acid derivatives

Also Published As

Publication number Publication date
DK157677A (da) 1978-01-03
CA1104130A (en) 1981-06-30
US4136197A (en) 1979-01-23
FR2356631B1 (US20020051482A1-20020502-M00057.png) 1981-02-27
CH627737A5 (de) 1982-01-29
BE853258A (fr) 1977-10-05
CH631155A5 (de) 1982-07-30
CH630063A5 (de) 1982-05-28
ATA245377A (de) 1978-11-15
GB1530062A (en) 1978-10-25
DE2629752A1 (de) 1978-01-05
NL7703641A (nl) 1978-01-04
JPS535148A (en) 1978-01-18
FR2356631A1 (fr) 1978-01-27

Similar Documents

Publication Publication Date Title
AT349000B (de) Verfahren zur herstellung von neuen trans-4- cyclohexan-1-carbonsaeureestern
AT348999B (de) Verfahren zur herstellung von neuen biphenylcarbonsaeureestern
ATA939775A (de) Verfahren zur herstellung von neuen 3-amino-indazolcarbonsaure- derivaten
ATA348877A (de) Verfahren zur herstellung von neuen n- acylierten
AT345795B (de) Verfahren zur herstellung von neuen phenylalkancarbonsaeure-derivaten
AT349634B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosiden
ATA448177A (de) Verfahren zur herstellung von neuen dipeptid- derivaten
AT352279B (de) Verfahren zur herstellung von neuen rifamyzin- verbindungen
ATA33277A (de) Verfahren zur herstellung von neuen diphosphonalkancarbonsauren
ATA432877A (de) Verfahren zur herstellung von neuen dipeptid- derivaten
AT350545B (de) Verfahren zur herstellung von neuen n- subistituierten carbonsaeureamiden
AT351675B (de) Verfahren zur herstellung von neuen clavulan- saeurethioaethern
ATA303477A (de) Verfahren zur herstellung von neuen indazolyl- (4-)-oxy-propanolaminen
AT347457B (de) Verfahren zur herstellung von neuen indolinospiropyranverbindungen
DD131560A5 (de) Verfahren zur herstellung von neuen carbonsaeureestern
AT346301B (de) Verfahren zur herstellung von n- (alfa- alkoxyaethyl)-carbonsaeureamiden
AT352280B (de) Verfahren zur herstellung von neuen rifamyzin- verbindungen
DD130349A5 (de) Verfahren zur herstellung von zimtsaeureamiden
AT348502B (de) Verfahren zur herstellung von zum teil neuen alfa-ketocarbonsaeureamiden
ATA862276A (de) Verfahren zur herstellung von neuen n-methyl- sulfonyl- oder n-sulfamoyl-n-phenyl- bzw. -n- (3'-pyridyl)-pentahalogenaethylsulfensaeureamiden
ATA167678A (de) Verfahren zur herstellung von neuen n- substituierten carbonsaeureamiden
AT351558B (de) Verfahren zur herstellung von neuen 2-formyl- amino-phenylguanidinen
ATA326378A (de) Verfahren zur herstellung von neuen anthranil- saeureestern
AT342555B (de) Verfahren zur herstellung von neuen 2-methyl-3-buten-3-halogen-2-olen
ATA475677A (de) Verfahren zur herstellung von neuen phenylalkancarbonsaeure-derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee